Biofilm probiotic effective in preventing necrotizing enterocolitis in piglet model
Necrotizing enterocolitis (NEC) is a debilitating and deadly condition that affects infants who were born preterm.
Stay updated with breaking news from Perinatal Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Necrotizing enterocolitis (NEC) is a debilitating and deadly condition that affects infants who were born preterm.
<p>Researchers at Nationwide Children’s Hospital have been working on a novel solution to prevent NEC. They have developed a novel probiotic system that harnesses the durability of biofilms to improve the administration of probiotics to patients. It has been licensed to Scioto Biosciences. Their latest study, published in <em>Nature Scientific Reports</em>, describes the use of a biofilm formulation of <em>Limosilactobacillus reuteri </em>(<em>Lr</em>) to prevent NEC in a piglet model.</p>
A research team at Nationwide Children’s Hospital and The Ohio State University Wexner Medical Center was recently awarded $17.7 million from the National Institutes of Health (NIH) to join a national consortium to study how childhood environments and experiences influence the health of children as they grow and develop.
The University of Kentucky Cannabis Center opened last year.
Four researchers have been selected for grants and represent the College of Nursing, College of Public Health, College of Pharmacy and the Martin School of Public Policy and Administration. Awards in the amount of $75,000-$100,000 will fund studies for a period of 14 months.